英文名稱 Anti-BAP135/TFII I

中文名稱 蛋白酪氨酸激酶BAP135抗體

濃 度 1mg/1ml

規(guī) 格 0.2ml/200μg

抗體來源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human, Mouse, Rat

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶

蛋白分子量 predicted molecular weight: 135kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanBAP135/TFII I

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -81 °C for oneyear.

別 名 BAP 135; BAP135; Bruton tyrosine kinase associatedprotein 135; BTK associated protein 135; BTK associated protein 135kD; BTKassociated protein; BTKAP 1; BTKAP1; DIWS; General transcription factor II i;GTF 2I; GTF2I; GTFII I; IB 291; IB291; SPIN; SRF Phox 1 interacting protein;SRF Phox1 interacting protein; Transcription factor II I; WBS; WBSCR 6; WBSCR6;Williams Beuren syndrome chromosome region 6; Williams Beuren syndromechromosome region 6 protein.